Category Archives: 未分類

DAZZEON Biotech, upholding its core values of respecting and giving back to society, is dedicated to promoting social welfare and fulfilling corporate social responsibility. We have consistently supported charitable activities and donated to organizations such as the Jingren Disability Nursing Home and the Jintree Charity Foundation.

This year, 2024, we are further advancing our efforts by launching a new program to nurture promising sports talents, responding to the government's call to promote sports development. Through sponsoring emerging athletes, we aim to solidify our foundational support for sports talent, highly recognizing their value and injecting new momentum into Taiwan's sports industry.

DAZZEON Biotech has confirmed its sponsorship of Taiwanese golfer Babe Liu and completed the corporate sponsorship signing ceremony in February. We look forward to Babe Liu's outstanding performance in the upcoming Japan Ladies Professional Golf Tour (JLPGA) and wish her a bright future.

 

劉嬿 Babe Liu (JLPGA會員資訊)

IG: 劉嬿🐳Babe.Liu ，日本女子プロゴルフ協会（JLPGA）

DAZZEON Biotech has initiated a significant partnership with Hoshi Pharmaceutical University in Japan this February 2024, focusing on the research of aloe polysaccharide DM1001 for treating gastric mucosal lesions. Given Japan's consistently high rates of stomach cancer and the prevalence of gastric diseases, Hoshi Pharmaceutical University has shown keen interest in the potential of DM1001 for gastric mucosal repair.

This strategic collaboration aims to delve into the therapeutic potential of DM1001 against gastric diseases, particularly in combating stomach cancer. By working closely with Hoshi Pharmaceutical University, DAZZEON Biotech hopes to uncover the clinical efficacy and mechanisms of DM1001, offering new treatment avenues for stomach disease patients in Japan and worldwide. This partnership is expected to drive innovation in gastric disease treatment and foster further cooperation and exchange in biomedical research between the two parties.

In November 2023, leveraging the profound expertise in nanotechnology of our parent company, DAZZEON Technology, our company proudly launched a pioneering research initiative focused on nanofabrication processes and the preservation of biological activity.

This project is at the forefront of exploring how polysaccharides and other natural substances can be nano-engineered to serve as active ingredients or drug carriers, all while maintaining their inherent biological activities. Our aim is to utilize plant-based materials to develop a new generation of pharmaceuticals and medical devices, demonstrating the vast potential of nanotechnology applications in the biomedical field.